Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Tim Mayleben
AddedMar 31, 2024
UpdatedMay 31, 2026
Tim Mayleben

Tim Mayleben

Board Member, Wolverine Venture Fund

LinkedIn

Tim Mayleben's Career

Wolverine Venture Fund
Wolverine Venture Fund

Ann Arbor, MI, US

Board Member· Board
Landos Biopharma
Landos Biopharma

Blacksburg, VA, US

Board Member· Board
Marinus Pharmaceuticals
Marinus Pharmaceuticals

Radnor, PA, US

Board Member· Board
Phlow
Phlow

Richmond, VA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Tim Mayleben's Career

Wolverine Venture Fund
Wolverine Venture Fund
Investment FirmInvestment Firm401997Ann Arbor, MI, US
Board Member· Board

Similar to Wolverine Venture Fund

Wolverine AngelsWolverine AngelsLos Angeles, CA, USWolverine AngelsLos Angeles, CA, US

Wolverine Angels: A syndicate connecting U of M community with investment opportunities, fostering entrepreneurship.

Investment Firm3
W FundW FundSeattle, WA, USest. 2012W FundSeattle, WA, US · est. 2012

W Fund: A tech-focused venture fund investing in Washington's promising start-ups from research institutions.

Investment Firm5
Van Wickle VenturesVan Wickle VenturesProvidence, RI, USest. 2019Van Wickle VenturesProvidence, RI, US · est. 2019

Van Wickle Ventures: A student-run venture fund offering career opportunities and fostering a balanced work culture.

Investment Firm13
Social Venture FundSocial Venture FundAnn Arbor, MI, USest. 2010Social Venture FundAnn Arbor, MI, US · est. 2010

Social Venture Fund: A US-based venture capital firm investing in education, health, environment, and urban sectors.

Investment Firm30
Landos Biopharma
Landos Biopharma
Public$70M372017Blacksburg, VA, US
Board Member· Board

Leadership at Landos Biopharma

Josep Bassaganya-RieraJosep Bassaganya-RieraBoard Member
Chris GarabedianChris GarabedianBoard Member
Roger AdsettRoger AdsettBoard Member
Tiago GiraoTiago GiraoBoard Member
Gregory OakesGregory OakesBoard Member

Similar to Landos Biopharma

Lapix TherapeuticsLapix TherapeuticsBoston, MA, USDrugs, Therapeuticsest. 2020Lapix TherapeuticsBoston, MA, US · est. 2020

Lapix Therapeutics: Enhancing immune response and drug safety through targeted therapeutic modulation.

Series A · $5.9M9
Lumos PharmaLumos PharmaAustin, TX, USPharmaceuticals, Therapeuticsest. 1999Lumos PharmaAustin, TX, US · est. 1999

Lumos Pharma: A global biopharmaceutical firm based in Austin, US, specializing in rare disease therapeutics.

Public · $53.5M29
Palisade BioPalisade BioCarlsbad, CA, USTherapeuticsest. 2001Palisade BioCarlsbad, CA, US · est. 2001

Palisade Bio, Inc.: A global biopharmaceutical firm innovating therapies for gastrointestinal complications.

Public · $55.4M12
Bond BiosciencesBond BiosciencesNew York City, NY, USPharmaceuticals, Therapeuticsest. 2016Bond BiosciencesNew York City, NY, US · est. 2016

Bond Biosciences: A private biopharma firm developing non-absorbed oral therapeutics for human diseases.

Series B · $11.8M7
Marinus Pharmaceuticals
Marinus Pharmaceuticals
Public$406.9M1512003Radnor, PA, US
Board Member· Board

Leadership at Marinus Pharmaceuticals

Scott BraunsteinScott BraunsteinBoard Member
Harry H. PennerHarry H. PennerFounder
Elan EzicksonElan EzicksonBoard Member
Seth FischerSeth FischerBoard Member
Harry T ReinHarry T ReinBoard Member
Nicole VitulloNicole VitulloBoard Member

Similar to Marinus Pharmaceuticals

Supernus PharmaceuticalsSupernus PharmaceuticalsRockville, MD, USPharmaceuticalsest. 2005Supernus PharmaceuticalsRockville, MD, US · est. 2005

US-based Supernus Pharmaceuticals develops and markets proprietary drugs for central nervous system disorders.

Public · $689.5M612
Marius PharmaceuticalsMarius PharmaceuticalsRaleigh, NC, USPharmaceuticalsest. 2017Marius PharmaceuticalsRaleigh, NC, US · est. 2017

Marius Pharmaceuticals: A biopharmaceutical firm innovating patient-centric therapies for hypogonadism.

Series A · $32.6M19
Sea PharmaceuticalsSea PharmaceuticalsCambridge, MA, USPharmaceuticalsest. 2013Sea PharmaceuticalsCambridge, MA, US · est. 2013

Sea Pharmaceuticals develops innovative oral treatments for neurological disorders like tinnitus and epilepsy.

Seed · $1.7M8
AptinyxAptinyxEvanston, IL, USPharmaceuticalsest. 2015AptinyxEvanston, IL, US · est. 2015

Aptinyx Inc., a US-based bio-pharmaceutical company, specializes in developing novel treatments for brain and nervous system disorders.

Public · $273.9M12
Phlow
Phlow
Series B$80.2M602020Richmond, VA, US
Board Member· Board

Leadership at Phlow

Frank GuptonFrank GuptonCo-Founder
Eric EdwardsEric EdwardsCo-Founder
Marshall SummarMarshall SummarBoard Member

Similar to Phlow

Continuity PharmaContinuity PharmaWest Lafayette, IN, USManufacturing Systemsest. 2018Continuity PharmaWest Lafayette, IN, US · est. 2018

Continuity Pharma: Modern, efficient systems for manufacturing essential generic medicines.

Seed · $1.5M9
BiotechInnovaBiotechInnovaFlorida, NY, USPharmaceuticalsBiotechInnovaFlorida, NY, US

BiotechInnova: A Florida-based pharmaceutical manufacturer with robust technical and regulatory expertise.

Seed · $250k30
Bright Path LaboratoriesBright Path LaboratoriesKannapolis, NC, USPharmaceutical Manufacturingest. 2019Bright Path LaboratoriesKannapolis, NC, US · est. 2019

Bright Path Labs: Agile, scalable pharmaceutical manufacturing tech provider, addressing drug shortages and future health challenges.

Series A · $8.5M23
PleoPharmaPleoPharmaPhoenixville, PA, USPharmaceuticalsest. 2020PleoPharmaPhoenixville, PA, US · est. 2020

PleoPharma: A high-ethics pharmaceutical firm dedicated to addressing significant medical needs.

Series A · $11.1M30

Tim Mayleben's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Tim Mayleben

Rick KlausnerRick KlausnerBoard Member · Lyell ImmunopharmaTadas MaurukasTadas MaurukasCo-Founder · LympoMichael HuffordMichael HuffordCEO · MorphoceuticalsLynn SeelyLynn SeelyBoard Member · Lyell ImmunopharmaMike LongMike LongBoard Member · Essence Group HoldingsJohn BurdJohn BurdCEO · Lysulin